Effects of exogenous lactate on lipid, protein, and glucose metabolism-a randomized crossover trial in healthy males.
Mette Glavind Bülow PedersenNikolaj Fibiger RittigMaj BangshaabKristoffer Berg-HansenNigopan GopalasingamLars Christian GormsenEsben SøndergaardNiels MøllerPublished in: American journal of physiology. Endocrinology and metabolism (2024)
Lactate may inhibit lipolysis and thus enhance insulin sensitivity, but there is a lack of metabolic human studies. This study aimed to determine how hyperlactatemia affects lipolysis, glucose- and protein metabolism, and insulin sensitivity in healthy men. In a single-blind, randomized, crossover design, eight healthy men were studied after an overnight fast on two occasions: 1 ) during a sodium-lactate infusion (LAC) and 2 ) during a sodium-matched NaCl infusion (CTR). Both days consisted of a 3-h postabsorptive period followed by a 3-h hyperinsulinemic-euglycemic clamp (HEC). Lipolysis rate, endogenous glucose production (EGP), and delta glucose rate of disappearance (ΔRd glu ) were evaluated using [9,10- 3 H]palmitate and [3- 3 H]glucose tracers. In addition, whole body- and forearm protein metabolism was assessed using [ 15 N]phenylalanine, [ 2 H 4 ]tyrosine, [ 15 N]tyrosine, and [ 13 C]urea tracers. In the postabsorptive period, plasma lactate increased to 2.7 ± 0.5 mmol/L during LAC vs. 0.6 ± 0.3 mmol/L during CTR ( P < 0.001). In the postabsorptive period, palmitate flux was 30% lower during LAC compared with CTR (84 ± 32 µmol/min vs. 120 ± 35 µmol/min, P = 0.003). During the HEC, palmitate flux was suppressed similarly during both interventions ( P = 0.7). EGP, ΔRd glu , and M value were similar during LAC and CTR. During HEC, LAC increased whole body phenylalanine flux ( P = 0.02) and protein synthesis ( P = 0.03) compared with CTR; LAC did not affect forearm protein metabolism compared with CTR. Lactate infusion inhibited lipolysis by 30% under postabsorptive conditions but did not affect glucose metabolism or improve insulin sensitivity. In addition, whole body phenylalanine flux was increased. Clinical trial registrations: NCT04710875. NEW & NOTEWORTHY Lactate is a decisive intermediary metabolite, serving as an energy substrate and a signaling molecule. The present study examines the effects of lactate on substrate metabolism and insulin sensitivity in healthy males. Hyperlactatemia reduces lipolysis by 30% without affecting insulin sensitivity and glucose metabolism. In addition, hyperlactatemia increases whole body amino acid turnover rate.
Keyphrases
- amino acid
- adipose tissue
- clinical trial
- open label
- double blind
- phase iii
- protein protein
- blood glucose
- phase ii
- low dose
- placebo controlled
- binding protein
- endothelial cells
- physical activity
- fatty acid
- blood pressure
- middle aged
- insulin resistance
- body composition
- weight loss
- bone mineral density
- metabolic syndrome
- postmenopausal women
- glycemic control